Compare JBHT & MDLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | JBHT | MDLN |
|---|---|---|
| Founded | 1961 | 1966 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Trucking Freight/Courier Services | Medical/Dental Instruments |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 26.7B | 31.0B |
| IPO Year | 1994 | 2025 |
| Metric | JBHT | MDLN |
|---|---|---|
| Price | $274.99 | $32.59 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 20 | 23 |
| Target Price | ★ $220.80 | $50.48 |
| AVG Volume (30 Days) | 704.7K | ★ 6.3M |
| Earning Date | 04-15-2026 | 05-06-2026 |
| Dividend Yield | ★ 0.73% | N/A |
| EPS Growth | ★ 10.07 | N/A |
| EPS | ★ 3.39 | 0.23 |
| Revenue | $7,189,568,000.00 | ★ $28,432,000,000.00 |
| Revenue This Year | $5.76 | $10.88 |
| Revenue Next Year | $6.62 | $7.69 |
| P/E Ratio | ★ $79.78 | $141.43 |
| Revenue Growth | 9.67 | ★ 11.47 |
| 52 Week Low | $130.13 | $31.87 |
| 52 Week High | $299.76 | $50.88 |
| Indicator | JBHT | MDLN |
|---|---|---|
| Relative Strength Index (RSI) | 48.98 | 37.06 |
| Support Level | $266.94 | N/A |
| Resistance Level | $292.15 | $37.39 |
| Average True Range (ATR) | 6.84 | 1.18 |
| MACD | 0.89 | -0.18 |
| Stochastic Oscillator | 65.00 | 12.32 |
J.B. Hunt Transport Services ranks among the top surface transportation companies in North America by revenue. Its primary operating segments are intermodal delivery, which uses the Class I rail carriers for the underlying line-haul movement of its owned containers (48% of sales), dedicated trucking services that provide customer-specific fleet needs (27%), for-hire truckload (6%), heavy goods final-mile delivery (7%), and asset-light truck brokerage (12%).
Medline is the largest provider of medical-surgical products and supply chain solutions in the US. The company generates over 90% of its revenue domestically and serves some of the largest US health systems. Medline offers approximately 190,000 Medline-branded products across more than 250 product families—including front-line care, surgical solutions, and laboratory and diagnostics—as well as roughly 150,000 third-party products sourced from over 1,250 vendors. The company maintains prime vendor relationships with many customers, acting as the primary consolidated logistics partner for their medical-surgical needs. Medline has significant scale, supported by more than 30 manufacturing facilities and a fleet of over 2,000 owned delivery trucks. Medline went public in December 2025.